📊 Score Breakdown
Offering Ability
60
Cash Runway
0
Float Risk
45
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
9%
💰 Capital Raise
18%
• Active ATM program with $10M remaining capacity
💹 Market Data
Market Cap$45.80M
Shares Outstanding5.78M
Float3.45M
Cash$137.53M
Debt$6.95M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 80.0% shares (2025Q4 vs prior)
37 institutional holders · 39.73M shares
#1
GILEAD SCIENCES, INC.
9.11M shares
#2
Bain Capital Life Sciences Investors, LLC
7.37M shares
#3
Frazier Life Sciences Management, L.P.
5.92M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest174.3K
Days to Cover5.9
% of Float5.1%
FINRA data as of Apr 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
xbrl
XBRL CONVERTIBLE
Dec 31, 2021
4
INSIDER TRANSACTION
Mar 30, 2026
4
INSIDER TRANSACTION
Feb 17, 2026
8-K
8K EVENT
Feb 12, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for XLO
📊 XLO FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 XLO Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.